Literature DB >> 8858786

Design and analysis of intra-subject variability in cross-over experiments.

V M Chinchilli1, J D Esinhart.   

Abstract

Recently, interest has grown in the development of inferential techniques to compare treatment variabilities in the setting of a cross-over experiment. In particular, comparison of treatments with respect to intra-subject variability has greater interest than has inter-subject variability. We begin with a presentation of a general approach for statistical inference within a cross-over design. We discuss three different statistical models where model choice depends on the design and assumptions about carry-over effects. Each model incorporates t-variate random subject effects, where t is the number of treatments. We develop maximum likelihood (ML) and restricted maximum likelihood (REML) approaches to derive parameter estimators and we consider a special case in which closed-form expressions for the variance component estimators are available. Finally, we illustrate the methodologies with the analysis of data from three examples.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858786     DOI: 10.1002/(SICI)1097-0258(19960815)15:15<1619::AID-SIM326>3.0.CO;2-N

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

1.  Subject-by-formulation interaction in bioequivalence: conceptual and statistical issues. FDA Population/Individual Bioequivalence Working Group. Food and Drug Administration.

Authors:  W W Hauck; T Hyslop; M L Chen; R Patnaik; R L Williams
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Bioequivalence of methylphenidate immediate-release tablets using a replicated study design to characterize intrasubject variability.

Authors:  M C Meyer; A B Straughn; E J Jarvi; K S Patrick; F R Pelsor; R L Williams; R Patnaik; M L Chen; V P Shah
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

3.  Variability in the bioavailability of phenytoin capsules in males and females.

Authors:  M C Meyer; A B Straughn; R M Mhatre; V P Shah; M L Chen; R L Williams; L J Lesko
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

4.  A matched crossover design for clinical trials.

Authors:  Laura J Simon; Vernon M Chinchilli
Journal:  Contemp Clin Trials       Date:  2007-02-27       Impact factor: 2.226

5.  Modeling the dose effects of soybean oil in salad dressing on carotenoid and fat-soluble vitamin bioavailability in salad vegetables.

Authors:  Wendy S White; Yang Zhou; Agatha Crane; Philip Dixon; Frits Quadt; Leonard M Flendrig
Journal:  Am J Clin Nutr       Date:  2017-08-16       Impact factor: 7.045

6.  Bioequivalence testing by statistical shape analysis.

Authors:  Luis Marcelo Pereira
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-06-07       Impact factor: 2.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.